This headline got my immediate attention: “No Benefit with Surgery for Low-Risk Prostate Cancer.” The article is based on follow up findings from the PIVOT randomized trial. They suggest that radical prostatectomy does not offer men with localized prostate cancer a significant survival benefit over active surveillance or other type of observation. For traditional urologists, this might seem close to heresy... keep reading

A good night’s sleep is essential for physical and mental health. Is there a connection between sleep disruption and risk of developing prostate cancer? This question may have been sparked by a Japanese study that found an increased prostate cancer risk among... keep reading

A multinational research team, including a urologist, radiologist and pathologist from UCLA, published a recent paper on the value of mpMRI for monitoring and reassessing low-risk prostate cancer patients on Active Surveillance... keep reading

High cholesterol is not your heart’s best friend, right? Everyone knows that! But what you may not know is the impact of high cholesterol on your PSA levels as well as risk of prostate cancer (PCa). As far back as 2014 we began posting blogs about the effects of statins—a class of drugs used to keep reading

When it comes to treating prostate cancer (PCa) with radiation, there’s a new kid on the block. Conventional external beam radiation therapy (EBRT) has been routinely performed for more than half a century. EBRT targets the whole gland. It is considered a safe and effective alternative to surgical gland removal (radical prostatectomy). Since its original keep reading

Is there a universal diet that can add benefits to boost the effectiveness of cancer treatments? The short answer is no, according to an interesting 2020 review of published research on dietary interventions and cancer. Instead of a single dietary plan for all cancers, it appears that a number of diets are better for some keep reading

I came across a July 6, 2022 commentary piece published in Journal of the American Medical Association (JAMA).[i] It raises an interesting 2-part question about focal treatment for prostate cancer (PCa): For which patients is this approach effective in controlling their PCa, and how is cancer control defined? The three authors hail from Ohio State keep reading

The respected journal Lancet Oncology has published the study results of focal therapy for intermediate risk PCa patients, as performed with MRI-guided focused ultrasound. The Sperling Prostate Center is proud to have been one of the study sites. keep reading

Are you newly diagnosed with prostate cancer (PCa) and deciding on a treatment? Are you on Active Surveillance and monitoring your PCa using biomarkers and MRI? Have you had a local treatment, either radical or focal, and are doing annual follow-up as instructed? Do you have advanced PCa controlled by androgen deprivation therapy (ADT)? Do keep reading

Aggressive prostate cancer (PCa) comes with higher chances for recurrence—and often there’s no way to know if the PCa has started to spread at the time of treatment. It’s like a time bomb with an unanswered question: has the clock been activated? Therefore, today’s clinical standard of care treats it as if the clock is keep reading